Acute myeloid leukemia Trials in Seattle, United States
Conditions / Acute myeloid leukemia / Seattle, United States
Research into Acute myeloid leukemia spans multiple therapeutic approaches and trial phases.
119 total trials for this combination
Showing top 10 of 119 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05564390 | MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) | RECRUITING | — |
| NCT05334069 | Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection | RECRUITING | — |
| NCT05554406 | Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) | RECRUITING | — |
| NCT03844048 | An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00309842 | Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases | COMPLETED | PHASE2 |
| NCT05564390 | MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) | RECRUITING | — |
| NCT05564390 | MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) | RECRUITING | — |
| NCT04726241 | The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study | RECRUITING | PHASE1/PHASE2 |
| NCT02521493 | Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04553692 | Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers | TERMINATED | PHASE1 |